Cooper-Standard Holdings Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Cooper-Standard Holdings Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,473	3,618	3,624	3,108	2,375	2,330	2,525	2,816	2,731	2,741
Cost of revenue	2,808	2,947	3,076	2,749	2,228	2,243	2,396	2,525	2,428	2,413
Gross profit	665	671	548	359	148	87.2	130	291	303	328
Research and development	118	128	123	115	102	90	80.5	84.1	82.8	80.6
Selling, general and administrative	357	341	315	302	264	227	199	216	208	214
Operating income	247	266	110	156	-269	-209	-105	46	69.8	86.6
Other non-operating income	-13.7	-9.38	-4.84	-4.26	-2.58	-4.84	-5.49	-15.7	-17.9	-0.93
Pre-tax income	195	213	69.7	98.3	-330	-289	-201	-194	-101	-23.5
Income tax	54.3	71.5	-29.4	36.1	-60.8	39.4	17.3	8.93	-23.3	-19.2
Net income to minority interests	1.45	3.27	-4.55	-5.32	-1.77	-6.01	-2.41	-1.33	0.62	-0.15
Net income	139	138	104	67.5	-268	-323	-215	-202	-78.7	-4.17
EBITDA	370	404	257	308	-114	-70.1	17.5	156	173	185
EPS, basic	7.96	7.76	5.79	3.94	-15.82	-18.94	-12.53	-11.64	-4.48	-0.23
EPS, diluted	7.42	7.35	5.66	3.92	-15.82	-18.94	-12.53	-11.64	-4.48	-0.23
Shares, basic (weighted)	17.5	17.8	17.9	17.1	16.9	17	17.2	17.4	17.6	17.9
Shares, diluted (weighted)	18.7	18.8	18.3	17.2	16.9	17	17.2	17.4	17.6	17.9

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	480	516	265	360	438	248	187	155	170	192
Receivables	461	494	419	423	380	317	359	381	311	334
Inventory	146	170	176	143	144	158	158	147	142	154
Other current assets	81	101	109	60.8	100	73.3	57.1	28.9	30.3	57.4
Total current assets	1,296	1,427	1,250	1,202	1,260	995	946	901	805	881
Property, plant and equipment	832	952	984	988	892	784	643	608	539	524
Lease right-of-use assets			0	83.4	110	111	94.6	91.1	87.3	83.5
Goodwill	167	172	144	142	142	142	142	141	140	141
Intangible assets	81.4	69.1	99.6	84.4	67.7	60.4	47.6	40.6	33.8	29
Other non-current assets	68	72	75.8	78.4	74.1	106	70.9	67	63.8	175
Total assets	2,492	2,726	2,624	2,636	2,612	2,226	1,964	1,872	1,733	1,833
Accounts payable	475	523	452	426	385	348	338	335	295	337
Accrued liabilities	106	146	103	120	111	101	119	117	117	114
Deferred revenue			0.14	0.06	0.03	0.14	0.02	0.02	0.01	0
Short-term debt	33.4	34.9	101	61.4	40.7	56.1	54.1	50.7	42.4	86.1
Total current liabilities	759	827	820	720	671	598	632	653	577	678
Long-term debt	729	723	730	746	983	981	982	1,045	1,058	1,018
Lease liabilities			0	60.2	90.5	92.8	77.6	76.5	71.9	69.8
Other non-current liabilities	44.7	68.7	37.2	34.2	32.8	42.4	34.5	52.8	40.5	40.3
Total liabilities	1,770	1,871	1,773	1,760	1,988	1,895	1,862	1,962	1,866	1,925
Total debt	763	758	831	808	1,023	1,037	1,036	1,095	1,100	1,105
Paid-in capital	514	513	502	490	499	504	507	512	518	524
Retained earnings	421	509	569	619	350	25.6	-190	-392	-471	-475
Other comprehensive income	-243	-198	-246	-254	-242	-205	-210	-202	-173	-133
Shareholders' equity	697	827	825	856	607	325	108	-81.3	-126	-83.5
Minority interests	24.4	28.5	26.7	19.8	17	6.48	-6.52	-8.43	-7.6	-8.09
Total equity	716	852	851	876	624	331	101	-89.7	-133	-91.6
Total liabilities and equity	2,492	2,726	2,624	2,636	2,612	2,226	1,964	1,872	1,733	1,833
Shares outstanding	17.7	17.9	17.6	16.8	16.9	17	17.1	17.2	17.3	17.6

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	140	141	99.1	62.2	-269	-329	-218	-203	-78.1	-4.31
Depreciation and amortization	123	138	147	152	154	139	122	110	104	98
Stock-based compensation	24	25	8.52	11.9	10.4	5.57	3.26	7.72	9.16	15.2
Deferred income tax	9.08	7.98	-38.9	15.9	-8.72	35.8	5.65	-5.81	-45.5	-35.1
Change in receivables	-0.58	-26.4	17.9	-26.5	94.1	52.7	-65.7	-12.3	67.8	-12.2
Change in inventory	6.65	-13.9	1.41	29.4	-15.2	-18.5	-2.22	6.41	-3.13	-4.36
Change in payables	70.1	11.4	-32.5	-14.6	-18.4	-25.5	20.6	6.74	-18.4	21.6
Cash from operations	365	313	149	97.7	-15.9	-116	-36.2	117	76.4	64.4
Capital expenditures	164	-187	-218	-164	-91.8	-96.1	-71.2	-80.7	-50.5	-48.2
Acquisitions	-37.5	-0.48	-172	-0.45	0	0
Cash from investing	-198	-201	-383	84	-107	-91.3	-17.9	-65	-45.1	-45.6
Debt issued	0	0
Debt repaid	-10.7	-19.9	-3.44	-4.49	-6.19	-5.53	-4.18	-2.13	-2.46	-2.26
Share buybacks	-23.8	-55.1	-60	-36.6	0	0
Cash from financing	-62.9	-75.5	-14.4	-84	208	3.21	-4.27	-81.1	-9.65	-3.97
Exchange rate effect	-0.67	-1.48	-3.02	-3.39	-3.07	11.1	-0.01	-0.92	-5.97	6.35
Net change in cash	104	35.5	-251	94.3	81.8	-192	-58.3	-29.7	15.6	21.2
Free cash flow	530	126	-68.7	-66.8	-108	-212	-107	36.5	25.9	16.3
Interest paid	38.6	47.4	44.9	47.6	55.7	73.2	80.2	78.7	102	114
Income taxes paid	38.3	36.9	32.3	23.6	1.68	6.74	-56.4	10.3	19.1	9.05

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $22.70 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	11.7%	Gross profit / revenue.
Operating margin	2.3%	Operating income / revenue.
EBITDA margin	5.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-2.8%	Pre-tax income / revenue.
Net margin	-2.0%	Net income / revenue.
FCF margin	-0.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	2.0%	Cash from operations / revenue.
Return on assets (ROA)	-3.0%	Net income / average total assets.
Return on invested capital (ROIC)	6.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	7.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.2%	Capital expenditures / revenue.
D&A / revenue	3.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	36.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	17.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	24.0%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	6.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	119.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-15.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-37.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	5.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-2.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-6.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.36x	Current assets / current liabilities.
Quick ratio	0.73x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.18x	(Cash + short-term investments) / current liabilities.
Debt / assets	58.6%	Total debt / total assets.
Liabilities / assets	107.4%	Total liabilities / total assets.
Net debt	$973.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	6.18x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$244.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	8.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$297.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.48x	Revenue / average total assets.
Fixed asset turnover	5.47x	Revenue / average property, plant and equipment.
Inventory turnover	13.0x	Cost of revenue / average inventory.
Days inventory	28 days	365 x average inventory / cost of revenue.
Receivables turnover	7.43x	Revenue / average receivables.
Days sales outstanding	49 days	365 x average receivables / revenue.
Days payables	56 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	22 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	108.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$3.13	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$153.76	Revenue / diluted weighted shares.
FCF per share	-$0.27	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.09	Cash from operations / diluted weighted shares.
Book value per share	-$7.35	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$16.76	Tangible book value / shares outstanding.
Cash per share	$7.12	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$403.4M	Share price x shares outstanding.
Enterprise value	$1.38B	Market cap + total debt - cash - short-term investments.
P/S	0.15x	Market cap / revenue.
P/OCF	7.22x	Market cap / cash from operations, when positive.
EV/Sales	0.50x	Enterprise value / revenue.
EV/EBIT	21.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.74x	Enterprise value / EBITDA, when both are positive.
FCF yield	-1.2%	Free cash flow / market cap.
Earnings yield	-14.0%	Net income / market cap (the inverse of P/E).

What was Cooper-Standard Holdings Inc.'s revenue in fiscal 2025?

Cooper-Standard Holdings Inc. reported revenue of $2.74B for fiscal 2025, 0.4% higher than the year before.

Was Cooper-Standard Holdings Inc. profitable in fiscal 2025?

No. It reported a net loss of $4.2M.

How much free cash flow did Cooper-Standard Holdings Inc. generate in fiscal 2025?

Cash from operations of $64.4M minus capital expenditures of $48.2M left free cash flow of $16.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Cooper-Standard Holdings Inc.